Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial

BACKGROUND: Trial on five plasma biomarkers (CA125, HE4, OPN, leptin, prolactin) and their possible role in differentiating benign from malignant ovarian tumors. METHODS: In this unicentric prospective trial preoperative blood samples of 43 women with ovarian masses determined for ovarian surgery we...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasenburg, A., Eichkorn, D., Vosshagen, F., Obermayr, E., Geroldinger, A., Zeillinger, R., Bossart, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447799/
https://www.ncbi.nlm.nih.gov/pubmed/34530759
http://dx.doi.org/10.1186/s12885-021-08682-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447799/
https://www.ncbi.nlm.nih.gov/pubmed/34530759
http://dx.doi.org/10.1186/s12885-021-08682-y

Ejemplares similares